RTTNews | Oct 5, 2020 10:51AM EDT

10:51 Monday, October 5, 2020 (RTTNews.com) - Shares of Axovant Gene Therapies Ltd. (AXGT) are climbing more than 15% Monday morning at $5.25. It has been trading in the range of $1.41- $6.93 in the last one year.

Axovant today said it plans to announce six-month safety and efficacy data from the second cohort of study of its investigational gene therapy for Parkinson's disease, AXO-Lenti-PD, on October 6.

AXO-Lenti-PD is a one-time gene therapy that works by delivering three genes involved in the production of dopamine directly to the brain.

Read the original article on RTTNews ( https://www.rttnews.com/3133871/stock-alert-axovant-advances-15.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved